Source: Center Watch

CaligorRx: Caligor appoints Andrea Chopek and Craig LaMarca to Clinical Trial Services Business Unit

Caligor Opco, which specializes in global comparator sourcing, early access to medicines and drug life-cycle management, has named two pharmaceutical executives to its Clinical Trial Services (CTS) business unit. Andrea Chopek has been appointed global head of Business Development for CTS. Craig LaMarca has been named global head of Business Development for TrialAssist, a business [...]The post Caligor appoints Andrea Chopek and Craig LaMarca to Clinical Trial Services Business Unit appeared first on CenterWatch News Online.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Lisa Rich-Milan's photo - CEO of CaligorRx

CEO

Lisa Rich-Milan

CEO Approval Rating

70/100

Read more